Radiotherapy Quality Assurance System Analyzes Dose in Isocentric Target Region
By MedImaging International staff writers Posted on 24 Nov 2009 |
In selecting a new quality assurance (QA) system for radiotherapy technology, cancer care physicists and physicians now have access to cutting-edge verification of radiation therapy treatment. Key to this is the capability to perform real dose measurements and analyze the dose in the isocentric target region, the volume of greatest concern.
Advocate Lutheran General Hospital, in the Chicago suburb of Park Ridge, IL, USA, has chosen ScandiDos (Uppsala, Sweden) as the provider of its QA solution for its RapidArc radiotherapy system, developed by Varian Medical Systems. (Palo Alto, CA, USA), and in doing so, becomes the 100th clinical installation of Delta4. The Delta4 system is in clinical use for intensity-modulated radiation therapy (IMRT), arc therapy, and TomoTherapy since 2006 at clinics worldwide.
As Advocate Lutheran General Hospital begins treating patients with RapidArc--one form of volumetric modulated arc therapy (VMAT) or intensity-modulated arc therapy (IMAT), having Delta4 for the pretreatment measurement and analysis of treatment plans will provide clinicians the comfort and confidence to proceed with these new, advanced treatments. Delta4's unique approach to measuring and presenting the dose data in three dimensions allows for quick, easy, and precise analysis of the treatment in relation to the prescription dose to the patient.
The advanced analysis software allows the medical physicist to quickly analyze the measured dose against the treatment plan to determine the significance and cause of deviations in the dose. Because VMAT/IMAT modalities such as RapidArc by Varian Medical Systems employ many more treatment angles than conventional IMRT, an integral part of the analysis of such is the delivery of dose from each of the actual gantry angles that will be delivered to the patient and the independent verification of each gantry angle as an element of the dose analysis. Delta4 is the only volumetric QA system on the market to perform this independent gantry angle verification, and, as such, accounts for this area of potential discrepancy as part of its measurement.
"We are very pleased that Advocate Lutheran General Hospital has chosen Delta4 PT as part of the technology solution to offer advanced radiation treatments to its patients,” stated Brad Dugai, national sales manager at ScandiDos.
"When we installed our first Delta4 in 2006, it was used to verify both IMRT and Arc Therapy treatments. Now, 3 years later, rotational therapy is becoming the new standard radiation therapy and, significantly, our 100th installed system will be used for both TomoTherapy and Varian RapidArc,” said Ingemar Wiberg, VP of sales and marketing at ScandiDos.
Delta4 has been used by linear accelerator manufacturers in the development and validation of arc therapy treatment modalities to include Varian's RapidArc and Elekta's (Stockhom, Sweden) VMAT system.
ScandiDos introduced the new QA standard in advanced radiotherapy by moving into the era of three-dimensional (3D) and 4D volumetric dosimetry. ScandiDos goal is to provide complete dosimetry solutions that enable clinics around the world to implement new treatment modalities satisfying the demand on accuracy in dose verification and patient throughput.
Related Links:
ScandiDos
Varian Medical Systems
Advocate Lutheran General Hospital, in the Chicago suburb of Park Ridge, IL, USA, has chosen ScandiDos (Uppsala, Sweden) as the provider of its QA solution for its RapidArc radiotherapy system, developed by Varian Medical Systems. (Palo Alto, CA, USA), and in doing so, becomes the 100th clinical installation of Delta4. The Delta4 system is in clinical use for intensity-modulated radiation therapy (IMRT), arc therapy, and TomoTherapy since 2006 at clinics worldwide.
As Advocate Lutheran General Hospital begins treating patients with RapidArc--one form of volumetric modulated arc therapy (VMAT) or intensity-modulated arc therapy (IMAT), having Delta4 for the pretreatment measurement and analysis of treatment plans will provide clinicians the comfort and confidence to proceed with these new, advanced treatments. Delta4's unique approach to measuring and presenting the dose data in three dimensions allows for quick, easy, and precise analysis of the treatment in relation to the prescription dose to the patient.
The advanced analysis software allows the medical physicist to quickly analyze the measured dose against the treatment plan to determine the significance and cause of deviations in the dose. Because VMAT/IMAT modalities such as RapidArc by Varian Medical Systems employ many more treatment angles than conventional IMRT, an integral part of the analysis of such is the delivery of dose from each of the actual gantry angles that will be delivered to the patient and the independent verification of each gantry angle as an element of the dose analysis. Delta4 is the only volumetric QA system on the market to perform this independent gantry angle verification, and, as such, accounts for this area of potential discrepancy as part of its measurement.
"We are very pleased that Advocate Lutheran General Hospital has chosen Delta4 PT as part of the technology solution to offer advanced radiation treatments to its patients,” stated Brad Dugai, national sales manager at ScandiDos.
"When we installed our first Delta4 in 2006, it was used to verify both IMRT and Arc Therapy treatments. Now, 3 years later, rotational therapy is becoming the new standard radiation therapy and, significantly, our 100th installed system will be used for both TomoTherapy and Varian RapidArc,” said Ingemar Wiberg, VP of sales and marketing at ScandiDos.
Delta4 has been used by linear accelerator manufacturers in the development and validation of arc therapy treatment modalities to include Varian's RapidArc and Elekta's (Stockhom, Sweden) VMAT system.
ScandiDos introduced the new QA standard in advanced radiotherapy by moving into the era of three-dimensional (3D) and 4D volumetric dosimetry. ScandiDos goal is to provide complete dosimetry solutions that enable clinics around the world to implement new treatment modalities satisfying the demand on accuracy in dose verification and patient throughput.
Related Links:
ScandiDos
Varian Medical Systems
Latest Radiography News
- Machine Learning Algorithm Identifies Cardiovascular Risk from Routine Bone Density Scans
- AI Improves Early Detection of Interval Breast Cancers
- World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
- AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
- Higher Chest X-Ray Usage Catches Lung Cancer Earlier and Improves Survival
- AI-Powered Mammograms Predict Cardiovascular Risk
- Generative AI Model Significantly Reduces Chest X-Ray Reading Time
- AI-Powered Mammography Screening Boosts Cancer Detection in Single-Reader Settings
- Photon Counting Detectors Promise Fast Color X-Ray Images
- AI Can Flag Mammograms for Supplemental MRI
- 3D CT Imaging from Single X-Ray Projection Reduces Radiation Exposure
- AI Method Accurately Predicts Breast Cancer Risk by Analyzing Multiple Mammograms
- Printable Organic X-Ray Sensors Could Transform Treatment for Cancer Patients
- Highly Sensitive, Foldable Detector to Make X-Rays Safer
- Novel Breast Cancer Screening Technology Could Offer Superior Alternative to Mammogram
- Artificial Intelligence Accurately Predicts Breast Cancer Years Before Diagnosis
Channels
MRI
view channel
New MRI Technique Reveals Hidden Heart Issues
Traditional exercise stress tests conducted within an MRI machine require patients to lie flat, a position that artificially improves heart function by increasing stroke volume due to gravity-driven blood... Read more
Shorter MRI Exam Effectively Detects Cancer in Dense Breasts
Women with extremely dense breasts face a higher risk of missed breast cancer diagnoses, as dense glandular and fibrous tissue can obscure tumors on mammograms. While breast MRI is recommended for supplemental... Read moreUltrasound
view channel
New Incision-Free Technique Halts Growth of Debilitating Brain Lesions
Cerebral cavernous malformations (CCMs), also known as cavernomas, are abnormal clusters of blood vessels that can grow in the brain, spinal cord, or other parts of the body. While most cases remain asymptomatic,... Read more.jpeg)
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read moreNuclear Medicine
view channel
New Imaging Approach Could Reduce Need for Biopsies to Monitor Prostate Cancer
Prostate cancer is the second leading cause of cancer-related death among men in the United States. However, the majority of older men diagnosed with prostate cancer have slow-growing, low-risk forms of... Read more
Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read moreGeneral/Advanced Imaging
view channel
First-Of-Its-Kind Wearable Device Offers Revolutionary Alternative to CT Scans
Currently, patients with conditions such as heart failure, pneumonia, or respiratory distress often require multiple imaging procedures that are intermittent, disruptive, and involve high levels of radiation.... Read more
AI-Based CT Scan Analysis Predicts Early-Stage Kidney Damage Due to Cancer Treatments
Radioligand therapy, a form of targeted nuclear medicine, has recently gained attention for its potential in treating specific types of tumors. However, one of the potential side effects of this therapy... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more